HGV related viral marker
Kobayashi, M.; Kiyosawa, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 6): 462-464
2010
ISSN/ISBN: 0047-1852 PMID: 20942104 Document Number: 640461
Document emailed within 1 workday
Related Documents
Misaki, M.; Shima, T.; Yano, Y.; Sumita, Y.; Kano, U.; Murata, T.; Watanabe, S.; Suzuki, S. 1990: Basement membrane-related and type IIi procollagen-related antigens in serum of patients with chronic viral liver disease Clinical Chemistry 36(3): 522-524Matsuura, K.; Tobe, K. 2004: Hepatitis B virus specific DNA polymerase activity as a sensitive marker of viral replication Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 8): 139-143
Matsuura, K.; Tobe, K.; Tsuji, T. 1995: Hepatitis B virus specific DNA polymerase activity as a sensitive marker of viral replication Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 2): 275-283
Thiers, V.; Bouchardeau, F.; Courouce, A.M.; Tiollais, P.; Brechot, C. 1986: Hepatitis B virus DNA as a marker of viral multiplication: comparison with HBe antigen and anti-HBe antibody Presse Medicale 15(26): 1219-1222
Qureshi, M.S.; Ahmad, M.; Khan, F.A.; Mushtaq, S.; Ahmed, S.A. 1987: Acute sporadic viral hepatitis--a sero marker study in 50 consecutive cases Jpma. Journal of the Pakistan Medical Association 37(9): 231-233
Maki, K. 1979: Viral hepatitis and HB antigen. Viral hepatitis and occupation-related diseases Nursing Technique 25(3): 96-111
Poston, G.J.; Seitz, P.K.; Townsend, C.M.; Alexander, R.W.; Rajaraman, S.; Cooper, C.W.; Thompson, J.C. 1987: Calcitonin gene-related peptide: possible tumor marker for medullary thyroid cancer Surgery 102(6): 1049-1054
Rodríguez Costa, T.; Gabarrón Llamas, J.; Casas Fernández, C.; Glover López, G.; Puche Mira, A.; Jiménez Cocina, A. 1984: Sex-related neurologic diseases. Familial X-linked mental retardation with a fragile X marker. Study of 8 families Anales Espanoles de Pediatria 21(Suppl 20): 54-57
Hazra, S.C.; Chatterjee, S.; Das Gupta, S.; Chaudhuri, U.; Jana, C.K.; Neogi, D.K. 2002: Changing scenario of transfusion-related viral infections Journal of the Association of Physicians of India 50: 879-881
Rawat, R.; Humphrey, J.H.; Mutasa, K.; Ntozini, R.; Stoltzfus, R.J. 2010: Short communication: predicting adverse HIV-related outcomes in a resource-limited setting: use of the inflammation marker α(1)-acid glycoprotein Aids Research and Human Retroviruses 26(11): 1171-1174
Oudenhoven, H.P.W.; Meijerink, H.; Wisaksana, R.; Oetojo, S.; Indrati, A.; van der Ven, A.J.A.M.; van Asten, H.A.G.H.; Alisjahbana, B.; van Crevel, R. 2011: Total lymphocyte count is a good marker for HIV-related mortality and can be used as a tool for starting HIV treatment in a resource-limited setting Tropical Medicine and International Health: Tm and Ih 16(11): 1372-1379
Reshad, K.; Inui, K.; Takahashi, Y.; Itoi, K.; Nakano, Y.; Sakamoto, M.; Suzuki, K. 1986: Serum squamous cell carcinoma-related antigen in lung cancer--a marker for the extent of the disease and response to therapy Nihon Kyobu Shikkan Gakkai Zasshi 24(8): 878-883
Taniwaki, M. 1985: New chromosome banding techniques with base specific antibiotics and fluorochromes for qualified identification of marker chromosomes in leukemia and related disorders Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(6): 1423-1439
Valle, M.C.; Martínez, L.C.; Ferreyra, L.J.; Giordano, M.O.; Isa, M.B.; Paván, J.V.; De Boccardo, G.; Massari, P.U.; Nates, S.V. 2001: Viral agents related to diarrheic syndrome in kidney transplanted patients Medicina 61(2): 179-182
Hosokawa, H.; Horio, S.; Takiuchi, Y.; Maruyama, N.; Asada, Y. 1984: Naturally occurring T lymphocytotoxic antibody in viral and related skin diseases Acta Dermato-Venereologica 64(4): 275-280
Tseng, B.W.; Chue, N.W.; Chen, K.T. 1987: Hepatitis-related viral markers in patients under long-term hemodialysis Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 20(4): 290-294
Biglino, A.; Cariti, G.; Gioannini, P. 1985: Circulating acid-labile interferon in chronic versus acute, HBV-related liver disease. a marker of immune-mediated hepatocellular damage? Bollettino dell'Istituto Sieroterapico Milanese 64(3): 201-206
Janeczko, J. 1973: Serum beta-glucuronidase activity in viral hepatitis as related to its therapeutic management Polski Tygodnik Lekarski 28(26): 972-975
Cokmert, S.; Demir, L.; Can, A.; Akyol, M.; Vedat Bayoglu, I.; Dirican, A.; Kucukzeybek, Y.; Erten, C.; Oktay Tarhan, M. 2014: Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 19(1): 75-82
Yang, Z.-B.; Wang, C.-G.; Gong, A.; Xie, Y.-f.; Liu, Q.; Yang, Q. 2013: Regulation of moxibustion for expression of gastric mucosa cell-related marker protein in rats with acute gastric ulcer Zhongguo Zhen Jiu 33(11): 1017-1021